Won't grow old for 100 years if...: What Ramdev said after Shefali Jariwala death
In an interview to NDTV, Ramdev said a normal human lifespan was "not 100 years, but 150-200 years", but that humans have put a lot of pressure on their brains, hearts, eyes and liver. He also reportedly said that food meant to be eaten over 100 years is being consumed by humans in 25 years.
He also claimed that one could stall growing old for up to 100 years if they monitor their diets properly. "You do not know how to operate yourself. If you keep doing well, then it is true that you will not grow old for 100 years," the news report quoted him as saying.
Ramdev's remarks on an average life-span and dietary habits comes days after Shefali Jariwala's death at the age of 42.
While a probe into her death is still underway, Mumbai Police found anti-ageing medicine, skin glow tablets and vitamin supplements at her apartment earlier, sparking a debate on the importance of maintaining a good lifestyle. Earlier, a heart attack was also suspected as a reason behind the actor's death, but the actual cause can only be known after a postmortem report is out.
When asked about Jariwala's death, Ramdev gave a hardware-software analogy, and said it was important for a human to be strong from the inside. "The hardware was fine, the software was faulty. The symptoms were fine, the system was faulty," Ramdev said.
Speaking on the subject of heart attacks, Ramdev said one shouldn't interfere with the body's natural life span, as it could lead to "disasters" internally and lead to heart attacks.
With a debate raging on the use of beauty enhancement supplements, Ramdev urged people to be "completely satisfied" in life and only focus on what they eat, how to they think and what is their physical strength.
"There is a difference in this superficial appearance. Appearing to be one and being one are different," Ramdev told NDTV.
Vouching for yoga, diet and a good lifestyle, Ramdev gave his example, saying he is completely fit even at the age of 60. Shefali Jariwala's death and lifestyle concerns
'Kaanta laga' fame Shefali Jariwala's death has brought attention to the importance of a good lifestyle. At just 42, the actor's death came as a shock to many.
A probe into her death have brought some significant things to light, like the the actor taking a vitamin C IV drip hours before she died, as confirmed by her friend Pooja Ghai in an interview.
Besides, the Mumbai Police found two boxes of beauty and self-care supplements at Jariwala's residence -- anti-ageing medicine, skin glow tablets and vitamin supplements. According to the actor's family, Shefali was not taking the tablets on a doctor's consultation.
Doctors at RN Cooper Hospital, where the actor's body was sent for a post mortem, are also suspecting that a sudden drop in blood pressure may have led to her death.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
7 hours ago
- India Today
Anti-ageing supplements alone don't cause heart attacks, clarifies Dr Naresh Trehan
The sudden death of actor Shefali Jariwala, known for her appearance in the 'Kaanta Laga' music video, has surprised one and all. On June 27, Jariwala while observing a fast at home, reportedly also took her regular anti-ageing supplements. She collapsed shortly after and was immediately rushed to the hospital, where doctors declared her death has reignited public concern. The question is simple: Why are young, seemingly fit individuals succumbing to heart failure? The blame this time around is being pinned on anti-ageing supplements — medications that Jariwala was reportedly taking regularly before the according to Dr Naresh Trehan, the narrative is more SCIENTIFIC LINK TO SUPPLEMENTS 'There is no conclusive scientific evidence linking supplements like glutathione directly to sudden cardiac death,' Dr Trehan says, adding, sudden cardiac arrests are the result of underlying conditions, most of which go undiagnosed until it's too to him, there are two major culprits: hypertrophic cardiomyopathy or dilated cardiomyopathy; structural heart diseases that are often undiagnosed until a serious event occurs. And the other is inherited electrical irregularities, such as Brugada syndrome, where the heart's electrical system is unstable and prone to dangerous arrhythmias."These conditions can manifest in young individuals without any prior symptoms. We've even seen cases of people dying in their sleep due to undiagnosed electrical or structural abnormalities,' he OF EXTERNAL TRIGGERSadvertisementWhile anti-ageing supplements alone may not be the cause, Dr Trehan acknowledges they can act as triggers, especially in individuals with existing but undiagnosed vulnerabilities.'External substances, including certain medications or supplements, may contribute to a cardiac event when combined with underlying heart conditions or physical stress,' he explains. 'But such events are episodic and unpredictable, making them extremely difficult to study in a clinical setting.'Dr. Trehan points to a disturbing trend: increasing cases of coronary artery disease in people as young as their 20s and 30s, particularly those with a family history of heart disease. 'Strenuous activity, including intense workouts or heavy lifting, in an undiagnosed individual, can trigger a cardiac event,' he BP DROPS TOO LOWIn a healthy heart, a drop in blood pressure (systolic pressure falls below 100 mmHg) can compromise blood flow to the Trehan says substances or supplements that could dilate blood vessels can exacerbate the pre-existing heart condition. He gives us an example: if a person with undiagnosed coronary blockages, thickened heart muscle, or a history of arrhythmias experiences a sudden drop in blood pressure or exerts themselves physically, the result can be cardiac triggers, such as critically low blood sugar (especially during fasting), may also play a ARE MULTI-FACTORIALadvertisement'These events are rarely caused by a single factor,' Dr Trehan emphasises. 'It's usually a combination of vulnerabilities like genetic predisposition, lifestyle, external substances, physical stress, and more that come together in a perfect storm.'This is why sudden cardiac deaths are so difficult to predict and prevent without thorough screening.A CARDIAC HOROSCOPE? Dr Trehan offers a practical solution: proactive heart screening.'We recommend that everyone, especially those with a family history of heart disease, diabetes, or unexplained medical events, undergo comprehensive cardiac screening by age 25—or even earlier.' Such screening could include echocardiography, lipid profile, and rhythm analysis.'Think of it as creating a cardiac horoscope, a predictive model of your personal health risks,' he says. 'With today's tools, including genome sequencing and advanced blood tests, we can detect hidden vulnerabilities and take preventive steps.'Sudden cardiac events may seem to strike out of nowhere, but many of them can be anticipated — and prevented — with timely diagnosis and like glutathione, in isolation, are unlikely to be the root cause. The real danger lies in what's hidden beneath the surface. A healthy lifestyle is important, but so is knowing what your heart might be silently carrying.- Ends advertisement
India.com
8 hours ago
- India.com
Shefali Jariwala's Sudden Death Raises Red Flags Over Anti-Ageing Treatments
The untimely death of Bollywood personality Shefali Jariwala, best known for her iconic role in Kaanta Laga, has sent shockwaves across the nation. At just 42, her sudden cardiac arrest on June 27, 2025, left fans and colleagues in disbelief. She was reportedly rushed to Bellevue Multispecialty Hospital in Andheri by her husband, actor Parag Tyagi, but was tragically declared dead on arrival. While police are still investigating the exact cause of her death, whispers around her long-term use of anti-ageing and skin-lightening treatments, including glutathione IV infusions, have come to the surface, raising serious concerns about the dark side of aesthetic wellness trends. What Experts Say: The Hidden Dangers of Anti-Ageing Therapies According to Dr BL Jangid, Dermatologist and Hair Transplant Surgeon at SkinQure Clinic, Delhi, the popularity of anti-ageing procedures, especially injectable treatments, has exploded in the last decade. 'From oral supplements to IV infusions, people are chasing youth without understanding the risks. And glutathione, unfortunately, is often marketed as a miracle,' warns Dr Jangid. What Is Glutathione and Why Is It Used? Glutathione is a natural antioxidant found in our body. It plays a key role in detoxification and cellular repair. In recent years, it has gained cult status in the skincare and wellness industry for: 1. Reducing pigmentation 2. Brightening the skin 3. Offering supposed 'anti-ageing' benefits It is available in oral capsules and intravenous infusions. And here's where the red flags begin. IV Glutathione: The Risky Shortcut to 'Youth' While oral glutathione supplements are generally safe under prescribed dosages, IV glutathione is far more controversial. The intravenous form introduces high doses directly into the bloodstream, often without proper regulatory guidelines. Dr Jangid reveals risks and possible side effects of IV Glutathione: 1. Allergic reactions and skin rashes 2. Inflammation and respiratory distress 3. Worsening of asthma symptoms 4. Damage to liver and kidney functions 5. Potential cardiac strain when administered in high, unregulated doses 'There are no globally accepted safety standards for IV glutathione doses,' says Dr Jangid. 'Unregulated clinics and salons offering such treatments are playing with people's lives.' What You Should Know Before Opting for Any Anti-Ageing Therapy 1. Always consult a qualified dermatologist or plastic surgeon 2. Avoid treatments at salons, spas, or unlicensed beauty clinics 3. If necessary, choose oral supplements under medical guidance 4. Demand full information about dosage, risks, and alternative options 'It's crucial to treat your skin like an organ, not a canvas. Anti-ageing should be medically monitored, not driven by trends,' Dr Jangid explains. Is Beauty Worth the Risk? Shefali's case may serve as a wake-up call. As aesthetics and beauty standards drive demand for quick fixes, consumers need to be better informed about the potential life-threatening complications of unregulated treatments. Dr Jangid stresses, "No anti-ageing result is worth endangering your life." Glutathione may promise a brighter, younger you, but when taken without medical supervision, especially via IV, it may lead to irreversible harm. Beauty, after all, is only skin deep. But your health? That's a life-or-death decision.
Economic Times
8 hours ago
- Economic Times
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala, best known for the 2002 chartbuster 'Kaanta Laga', due to cardiac arrest, has again brought to light the increasing trend of young, healthy and fit Indians suddenly dying of heart attack. In the past few years, several celebrities, such as Sidharth Shukla and Puneeth Rajkumar, have died due to cardiac issues. Heart attack incidents which used to affect mainly older adults now appear with increasing frequency among people under 50 years of age. The epidemic of cardiovascular diseases in India has created a lot of awareness about timely diagnosis among people which puts the focus on an emerging segment in India's healthcare sector -- diagnostics. India's diagnostics sector is undergoing a significant transformation, shifting from a fragmented business to a structured and tech-driven industry. Recently, Amazon announced its foray into the diagnostics space, marking a defining moment in this evolution. With an estimated market size of $25 billion and rapid growth, diagnostics is emerging as one of the most promising segments in Indian healthcare. But what triggered this boom? What forces are shaping its future? And is there a link to the rise in sudden heart attacks among India's young population? The COVID-19 pandemic was a catalyst that brought diagnostics to the forefront of healthcare. Once seen as a backend service, diagnostic testing has now become integral to proactive health management. More Indians are choosing routine screenings and preventive tests over symptomatic treatment. The shift in mindset, from illness-based to wellness-based healthcare, has been profound. This behavioral transformation laid the groundwork for diagnostics to flourish across urban and semi-urban the pandemic, diagnostic players were overloaded with work. Their bottom lines were getting better every single quarter. Between FY20 and FY22 – in just two years – literally all the companies saw a growth of more than 50% in absolute revenue numbers, as per a recent ET report. Once the pandemic ended, the workload returned to normal. The cash generated during Covid was utilized by different companies in different ways. Some used it to reduce their debt burden, others used it for expansion, using the cash for mergers that turned them from regional to national players. Post-pandemic, the demand for diagnostic services has surged, not only because of higher health awareness but also due to the lingering effects of the virus, which prompted many to seek tests related to heart health, respiratory function, and immune markers. India's recent diagnostics growth is also closely linked to the rising incidence of non-communicable diseases (NCDs). Conditions such as cardiovascular diseases (CVD), diabetes, hypertension and cancer are being detected at younger ages and are increasingly prevalent even in tier-2 and tier-3 cities. This has naturally escalated the demand for laboratory tests and imaging services. There has been a noted increase in sudden heart attacks among young and seemingly fit Indians, especially post-COVID. While there is no direct data attributing this to the boom in diagnostics, the phenomenon has contributed to an increase in cardiovascular screenings such as lipid profiles, ECGs and stress tests. As more individuals seek to understand their cardiac risk, diagnostics have become a proactive tool for early detection. The Indian diagnostics sector is transitioning rapidly from unorganised, standalone labs to structured, pan-India diagnostic chains. Organised players such as Dr Lal PathLabs, Metropolis, Thyrocare and SRL Diagnostics are increasing their footprints through franchise models and acquisitions. Organised diagnostic labs currently command around 15% market share but this is rising steadily, according to a recent report by PhillipCapital. The market is characterized by a high degree of fragmentation, with hospital-based labs holding a 37% share and unorganized standalone labs controlling the remaining 48%. Amazon India's recent launch of its diagnostics service in collaboration with Orange Health Labs is a significant milestone for the sector. The service, currently available in six major cities and 450+ PIN codes, offers over 800 tests with home sample collection in under 60 minutes and reports delivered within six entry not only validates the sector's growth potential but also intensifies competition. Following Amazon's announcement, shares of major diagnostic players like Dr Lal PathLabs and Metropolis fell by up to 3%, reflecting market concerns about pricing pressures and customer retention. Amazon brings scale, tech infrastructure and a convenience-first model, which could redefine customer expectations in diagnostics, especially in urban centers. One of the most promising aspects of the diagnostics sector is its expansion beyond metros. Non-metro cities are witnessing an annual growth rate of 20–25% in diagnostics demand, compared to 10% in metro cities. Rising health awareness, increasing affluence, and better insurance penetration are enabling residents in smaller towns to opt for preventive testing. Organised players are aggressively entering these markets, setting up franchise labs, mobile collection centers and even partnering with local clinics to provide high-quality testing services. The demand surge from rural and semi-urban areas is expected to play a pivotal role in the sector's growth trajectory over the next five years. Recently, Suraksha Diagnostics said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. The Indian government's healthcare initiatives, particularly Ayushman Bharat, have improved access to diagnostics for a broader population. Additionally, state-level Public-Private Partnership models in radiology, such as the Punjab government's tie-up with private players for operating MRI and CT scan centers, are helping bridge infrastructure insurance is also becoming more inclusive of diagnostics, covering pre-emptive testing and annual health checks. As out-of-pocket expenses decline, more individuals are accessing regular testing services, further supporting sectoral diagnostics sector remains under-penetrated compared to global standards. When measured by the number of tests conducted per person each year, India lags far behind other developing nations such as Brazil and Saudi Arabia--even though India has the largest population in the world. This indicates that there is still a huge untapped demand for diagnostics services in the country, as per the PhillipCapital report. The diagnostic sector in India is expected to grow at a compound annual growth rate (CAGR) of around 14% through FY2028, according to the PhillipCapital report. Radiology services alone are projected to expand from $7.1 billion in FY2025 to $13.5 billion by FY2030. The expansion will be led by increased adoption of AI in medical imaging, growth in home-based testing and broader genomic and personalised medicine challenges remain. Pricing pressures from new entrants like Amazon, quality standardisation in smaller labs and the need for improved regulation and accreditation are ongoing issues. The government and industry will need to work in tandem to ensure that growth does not compromise accuracy or Indian diagnostics sector is no longer an auxiliary healthcare service. It is becoming a central pillar of the country's healthcare ecosystem. Driven by lifestyle changes, epidemiological shifts, digital innovation, and consumer demand, the sector is poised for sustained expansion. Amazon's entry marks a shift from traditional models to a more consumer-focused, tech-enabled and scalable diagnostic future. While the rise in sudden heart attacks among the young has brought cardiovascular diagnostics into focus, the sector's momentum is supported by a much broader wave of preventive health consciousness sweeping the nation. Diagnostics in India is not just booming; it is evolving and preparing to redefine how 1.4 billion people manage their health.
